Brabant Pharma's Acquisition

Brabant Pharma was acquired by Zogenix on October 27, 2014.

Brabant Pharma is a single purpose company developing an oral treatment ("Brabafen") suitable for use in children with Dravet Syndrome (otherwise known as severe myoclonic epilepsy of infancy). Brabaf…

Articles about Brabant Pharma's Acquisition: